You've probably heard of most of the marijuana stocks with multibillion-dollar market caps. They're the ones that make headlines by establishing partnerships with big companies outside of the cannabis industry and teaming up with well-known celebrities. 

There's a good chance you've also heard of some marijuana stocks that aren't quite as large but are listed on U.S. stock exchanges. CannTrust and HEXO are good examples.

B.C. rang up $19.1 million in legal cannabis sales in 2018, just seven per cent of Canada’s overall marijuana revenue, even though the province makes up nearly 14 per cent of the national population, according to an analysis by Arcview Market Research.

In Alberta, however, legal sales — both recreational and medical — added up to $216.5 million, about 28 per cent of the nation’s overall legal revenue although that province is only 12 per cent of Canada’s population.

The marijuana industry has become quite dominated by companies that are working out of either the U.S. or Canadian cannabis space. Many companies have decided that the best mode of work is to put products forth in both markets which has become quite common. These companies, which are mostly the growers of the substance, have become some of the key players in the entirety of the industry. With so much opportunity coming out of the North American cannabis industry, it seems as though there are no signs of slowing down in sight.

CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX: TRST,NYSE: CTST) is pleased to announce that it has launched three new cannabis extract formulations to meet the growing demand for oil-based products. The new formulations are designed to fill previously unmet needs within the Canadian medical market, identified through market research and the Company’s long-standing relationships with thousands of medical cannabis patients and their healthcare practitioners.

CannTrust’s three new product formulations are:

 Several Canada-based marijuana growers could be impacted by a build-up of un-sellable “sub-par quality” cannabis, as well as a slower rollout of retail sales, one of Wall Street’s top marijuana analysts said Monday.

One reason marijuana quality can be poor is high level of moisture content. That’s why we’re highlighting THC Therapeutics, Inc. (THCT). The company’s dHydronator can reduce moisture content of cannabis to 10% in only 10-14 hours. Companies with products like THCT could help solve the industry’s quality problem.

The average cost of dried cannabis has gone up by more than 17 per cent since legalization, with consumers in New Brunswick and Manitoba seeing the biggest jumps, according to an analysis compiled by Statistics Canada.

As well, the cost of a legal gram of weed appears to be rising as illegal cannabis prices drop.

Statistics Canada said Wednesday the unweighted average price per gram of dried cannabis from both legal and illegal sources combined post-legalization was $8.04. That legal price, which includes online and in-store purchases, amounts to approximately 17.3 per cent more than the pre-legalization price of $6.85.

Of the 46 marijuana stocks in the North American Marijuana Index, I guess that a handful of them are currently making money. That’s the extent of it.

From that perspective, it’s a very daunting task picking the winners from the losers, because they all tell a good tale. But when it comes to separating the wheat from the chaff, the stocks to buy and sell aren’t nearly as easy to uncover.

When he arrived at the hospital by ambulance, the 70-year-old man said he felt like he was dying. He was pale, nauseated, and reported severe chest pain. "He had had hallucinations at home," says his doctor, Alexandra Saunders, MD, chief medical resident for Dalhousie University in St. John, New Brunswick, Canada. Soon, the medical team confirmed he’d had a heart attack.

More than 3 million people will be diagnosed with arthritis in the United States in 2019 alone, and an estimated 54 million are already living with the disease, according to the U.S. Centers for Disease Control and Prevention (CDC). Inflammation in the joints leads to pain, reduced range of motion, and stiffness in arthritic individuals, most of whom are older than 65. Prescription pain medication, over-the-counter pain relievers, and joint replacement surgeries are among the most common treatments for arthritis.

Cannabis e-commerce platforms, both medical and recreational, are becoming increasingly important as Canada's legal marijuana market matures.

However, given that only two of Canada's ten provinces—Manitoba and Saskatchewan—currently allow private marijuana retailers to sell cannabis online, online medical marijuana stores have continued to reign supreme in Canada's online cannabis market.

To get a better understanding of how Canada's online marijuana market is developing, we take a closer look at some of Canada’s most promising medical and recreational cannabis e-commerce platforms.